Pacira Biosciences, Inc. (PCRX)
36.40
+0.02
(+0.07%)
USD |
NASDAQ |
Oct 27, 16:00
36.40
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Market Cap : 1.450B for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 1.449B |
| October 23, 2026 | 1.450B |
| October 22, 2026 | 1.447B |
| October 21, 2026 | 1.447B |
| October 20, 2026 | 1.449B |
| October 19, 2026 | 1.447B |
| October 16, 2026 | 1.447B |
| October 15, 2026 | 1.447B |
| October 14, 2026 | 1.450B |
| October 13, 2026 | 1.446B |
| October 12, 2026 | 1.448B |
| October 09, 2026 | 1.446B |
| October 08, 2026 | 1.449B |
| October 07, 2026 | 1.004B |
| October 06, 2026 | 986.00M |
| October 05, 2026 | 997.55M |
| October 02, 2026 | 1.004B |
| October 01, 2026 | 995.96M |
| September 30, 2026 | 997.55M |
| September 29, 2026 | 1.021B |
| September 28, 2026 | 1.011B |
| September 25, 2026 | 1.000B |
| September 24, 2026 | 1.018B |
| September 23, 2026 | 980.82M |
| September 22, 2026 | 983.61M |
| Date | Value |
|---|---|
| September 21, 2026 | 960.12M |
| September 18, 2026 | 983.21M |
| September 17, 2026 | 974.85M |
| September 16, 2026 | 991.97M |
| September 15, 2026 | 958.92M |
| September 14, 2026 | 982.81M |
| September 11, 2026 | 1.010B |
| September 10, 2026 | 1.002B |
| September 09, 2026 | 1.031B |
| September 08, 2026 | 1.030B |
| September 04, 2026 | 1.049B |
| September 03, 2026 | 1.059B |
| September 02, 2026 | 1.058B |
| September 01, 2026 | 1.054B |
| August 31, 2026 | 1.031B |
| August 28, 2026 | 1.026B |
| August 27, 2026 | 1.029B |
| August 26, 2026 | 1.031B |
| August 25, 2026 | 1.017B |
| August 24, 2026 | 989.98M |
| August 21, 2026 | 982.42M |
| August 20, 2026 | 948.97M |
| August 19, 2026 | 970.07M |
| August 18, 2026 | 955.74M |
| August 17, 2026 | 925.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viatris, Inc. | 21.64B |
| Liquidia Corp. | 4.048B |
| Organon & Co. | 3.610B |
| ANI Pharmaceuticals, Inc. | 1.610B |
| Corcept Therapeutics, Inc. | 9.466B |
Market Cap Related Metrics
| PE Ratio | 104.88 |
| PS Ratio | 2.057 |
| Price to Book Value | 2.157 |
| Price to Free Cash Flow | 8.550 |
| Price | 36.40 |
| Earnings Yield | 0.95% |
| Operating PE Ratio | 55.55 |
| Normalized PE Ratio | 74.72 |